332 results on '"Xiu, Meihong"'
Search Results
2. Interaction between baseline BMI and baseline disease severity predicts greater improvement in negative symptoms in first-episode schizophrenia
3. Association of P50 with social function, but not with cognition in patients with first-episode schizophrenia
4. Association between angiotensin-converting enzyme gene insertion/deletion polymorphism and cognition impairment in patients with schizophrenia
5. The Impact of School Education on Depressive Symptoms in Chinese Adolescents: a Prospective Longitudinal Study
6. Cognitive improvements linked to lysophosphatidylethanolamine after olanzapine treatment in drug-naïve first-episode schizophrenia
7. Author Correction: A pilot study to examine the association between COX-2 rs5275 polymorphism and the response to repetitive transcranial stimulation in schizophrenia
8. Grouping motivational interviewing is only effective for younger patients with alcohol dependence in the rehabilitation stage
9. Sex difference in association between cognitive and P50 deficits in patients with chronic schizophrenia
10. Early efficacy of rTMS intervention at week 2 predicts subsequent responses at week 24 in schizophrenia in a randomized controlled trial
11. Neutrophil/lymphocyte ratio and cognitive performances in first-episode patients with schizophrenia and healthy controls
12. Sex-related differences in parental rearing patterns in young adults with bipolar disorder
13. A pilot study to examine the association between COX-2 rs5275 polymorphism and the response to repetitive transcranial stimulation in schizophrenia
14. Efficacy of standard operating procedures for fall protection in hospitalized patients with schizophrenia
15. Dance/movement therapy for improving balance ability and bone mineral density in long-term patients with schizophrenia: a randomized controlled trial
16. Obesity, antioxidants and negative symptom improvement in first-episode schizophrenia patients treated with risperidone
17. The neutrophil-lymphocyte ratio in first-episode medication-naïve patients with schizophrenia: A 12-week longitudinal follow-up study
18. Total antioxidant capacity, obesity and clinical correlates in first-episode and drug-naïve patients with schizophrenia
19. Sex differences in prevalence and clinical correlates of insomnia in Chinese patients with chronic schizophrenia
20. Association between cognitive function and IL-18 levels in schizophrenia: Dependent on IL18 − 607 A/C polymorphism
21. Associations between resilience and symptoms of depression and anxiety among adolescents: Examining the moderating effects of family environment
22. Glucose metabolism, hippocampal subfields and cognition in first-episode and never-treated schizophrenia
23. Sex difference in association between tardive dyskinesia and cognitive deficits in patients with chronic schizophrenia
24. Demographics, clinical characteristics and cognitive symptoms of heavy smokers and non-heavy smokers in Chinese male patients with chronic schizophrenia
25. Smoke, GPx activity and symptoms improvement in patients with drug-naive first-episode schizophrenia: A large-scale 12-week follow-up study
26. Tardive dyskinesia in Chinese patients with schizophrenia: Prevalence, clinical correlates and relationship with cognitive impairment
27. Low-Dose Ziprasidone in Combination with Sertraline for First-Episode Drug-Naïve Patients with Schizophrenia: a Randomized Controlled Trial
28. The effect of transcranial direct current stimulation combined with working memory training on working memory deficits in schizophrenic patients: study protocol for a randomized controlled trial
29. Serum BDNF levels, glycolipid metabolism in deficit schizophrenia: A case-control study
30. Association Between Hippocampal Subfields and Clinical Symptoms of First-Episode and Drug Naive Schizophrenia Patients During 12 Weeks of Risperidone Treatment
31. Sex differences in P50 inhibition defects with psychopathology and cognition in patients with first-episode schizophrenia
32. Correlations of religious beliefs with anxiety and depression of Chinese adolescents
33. Glucose Metabolism and Sex Hormones in Male Patients with Medication-naïve First-episode Schizophrenia: A Large-scale Cross-sectional Study
34. Association between the improvement in depressive symptoms and serum BDNF levels in drug-naive first episode patients with schizophrenia: A longitudinal follow-up
35. Plasma linoelaidyl carnitine levels positively correlated with symptom improvement in olanzapine-treated first-episode drug-naïve schizophrenia
36. P50 inhibition defects with psychopathology and cognitive impairment in patients with first-episode drug naïve schizophrenia
37. BDNF affects the mediating effect of negative symptoms on the relationship between age of onset and cognition in patients with chronic schizophrenia
38. Diabetes mellitus, cognitive deficits and serum BDNF levels in chronic patients with schizophrenia: A case-control study
39. Sex differences in association between clinical correlates and cognitive impairment in patients with chronic schizophrenia
40. Prevalence of obesity and clinical and metabolic correlates in first-episode schizophrenia relative to healthy controls
41. Elevated activity of plasma superoxide dismutase in never-treated first-episode schizophrenia patients: Associated with depressive symptoms
42. The prevalence, risk factors and clinical correlates of diabetes mellitus in Chinese patients with schizophrenia
43. P50 inhibition deficit in patients with chronic schizophrenia: Relationship with cognitive impairment of MATRICS consensus cognitive battery
44. Obesity in Chinese patients with chronic schizophrenia: Prevalence, clinical correlates and relationship with cognitive deficits
45. Interaction of oxidative stress and BDNF on executive dysfunction in patients with chronic schizophrenia
46. Parental marital status and anxiety symptoms in adolescents: the mediating effect of childhood maltreatment
47. Association of P50 with social function, but not with cognition in patients with first-episode schizophrenia
48. Baseline BMI is associated with clinical symptom improvements in first-episode schizophrenia: a longitudinal study
49. Glucose disturbances, cognitive deficits and white matter abnormalities in first-episode drug-naive schizophrenia
50. Association of cigarette smoking with cognitive impairment in male patients with chronic schizophrenia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.